Clinical significance of high expression of a specific solute carrier transporter in HCC.

Authors

null

Patricia Gifu

Cancer Research Center of Lyon, Lyon, France

Patricia Gifu , Sonia Brun , Guanxiong Wang , Firas Bassissi , Claude Caron de Fromentel , Philippe Merle , Philippe Halfon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 303)

DOI

10.1200/JCO.2018.36.4_suppl.303

Abstract #

303

Poster Bd #

E12

Abstract Disclosures

Similar Posters

First Author: Neehar Parikh

Poster

2015 Gastrointestinal Cancers Symposium

Recurrence-free survival results from a pilot study of adjuvant gefitinib in resected hepatocellular carcinoma (HCC).

Recurrence-free survival results from a pilot study of adjuvant gefitinib in resected hepatocellular carcinoma (HCC).

First Author: Akhil Chopra